RELEASE  February 5th, 2019

Oy Finnsusp Ab has developed a unique preservative-free eyelid spray (Class IIb Medical Device) for dry eyes, eyelids and eye contour. Moisturizing effect of the spray is a result of innovative active agents sea buckthorn oil and hyaluronan, both of which have clinically proven effects on treating dry eyes1, 2. A three-phase clinical study was carried out in Turku, Finland, to investigate the effects of this sea buckthorn seed oil – hyaluronic acid containing eyelid spray emulsion on dry eye. Elsevier Ltd on behalf of British Contact Lens Association has approved a peer-reviewed article about the clinical study and its results for publication in Contact Lens and Anterior Eye (CLAE). 

Link to the article: https://www.sciencedirect.com/science/article/pii/S1367048418309123            

The study was carried out as a randomized controlled study. Adults of 25–70 years with Ocular Surface Disease Index (OSDI) ≥20 and moderate or severe dryness were included. Dry eye tests were carried out at baseline, during, and at the end of each study section. 

Conclusions: Beneficial effects were found with the eyelid spray for symptoms of dry eye. The improvement of dry eye symptoms was significant compared to a commercial reference spray and when compared to the untreated control eye during the third study phase. 

The preservative-free and alcohol-free eyelid spray is sold by its original brand Piiloset BioDrop MD® Spray as well as by several private label brands in Europe, Canada and the Middle East. This eyelid spray is effective and an easy-to-use dry eye product for anyone with dry eyes. The product is safe to use during contact lens wear, too. The product utilizes unvented pouch-in-bottle system enabling 360° application for persons needing assistance.

  

For more information, please contact

Mrs. Riikka Järvinen, EVP, PhD, riikka.jarvinen@piiloset.fi

Mr. Markus Tenovuo, Sales Director, M.Sc. (Tech.), markus.tenovuo@piiloset.fi

  

References:

1 Larmo P. et al., Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. Journal of Nutrition 2010, 140/8):1462-8

2 Aragona P. et al., Long-term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002; 181-184.

 

Founded in 1978, Oy Finnsusp Ab is a Finnish privately owned family business that develops and manufactures Medical Devices. The product portfolio comprises FreeForm spectacle lenses, care solutions for contact lenses and eye care products – also for pets. The products are exported to over 30 countries in Europe, the Middle East, South America and North Africa. The ISO 13485:2016, MDSAP  and Brazilian GMP certified company provides also laboratory services and contract manufacturing services especially for the Medical Device industry.